B-cell receptor specific for H5 influenza hemagglutinin (H5-specific BCR)

Host B-cell receptors (BCRs) specific for H5 hemagglutinin (HA) epitopes are specialized membrane-bound immunoglobulins that recognize the primary surface glycoprotein of H5-subtype influenza viruses, such as H5N1 (Source: Janeway's Immunobiology). These receptors are central to the adaptive immune system's ability to defend against avian influenza, as their activation leads to the production of neutralizing antibodies that block viral entry into host cells (Source: Nature Reviews Immunology, 2018). In the context of H5N1, these receptors are the focus of vaccine design aimed at inducing broad-spectrum immunity to prevent pandemic spread (Source: WHO, 2023). Furthermore, these BCRs serve as the biological template for the discovery of therapeutic monoclonal antibodies, which are cloned from H5-specific B cells of convalescent or vaccinated individuals (Source: Science, 2009). The interaction between these BCRs and the HA stem region is particularly significant for the development of universal influenza vaccines (Source: Cell, 2015). However, the high rate of antigenic drift in the H5 hemagglutinin poses a challenge, as mutations can reduce the binding affinity of existing BCRs, leading to immune evasion (Source: CDC, 2022).

Other names

H5-HA specific B-cell receptorAnti-H5 hemagglutinin BCRH5N1-specific B-cell receptorH5-reactive B-cell receptor

Vaccine antigens bind to and cross-link specific B-cell receptors, triggering signal transduction through the Ig-alpha/Ig-beta complex, which leads to B-cell proliferation, affinity maturation, and differentiation into memory B cells and antibody-secreting plasma cells.